A hospital-based observational study on HIV-TB co-infection
Open Access
- 1 August 2025
- journal article
- tuberculosis
- Published by Microbiology Society in Access Microbiology
- Vol. 7 (8) , 000787.v4
Abstract
Background. Human immunodeficiency virus (HIV) is the major cause of failure to reach targets of tuberculosis (TB) control in settings with high HIV loads. TB, on the other hand, enhances the progression of HIV infection to AIDS. This study was done to understand the epidemiological and clinical profile of HIV-TB co-infected patients and to study the impact of TB on the recovery of CD4 counts. Methodology. An observational study was conducted in which of the 573 patients newly diagnosed with HIV infection and enrolled at the antiretroviral therapy (ART) centre, King George’s Medical University, Lucknow, between May 2021 and June 2022, 80 patients who also had newly diagnosed TB were included. These HIV-TB co-infected patients were analysed for demographic factors. Also, clusters of differentiation 4 (CD4) counts were done at the time of enrolment on ART and then later, ~6 to 8 months of recieving ART and anti-tubercular treatment (ATT) initiation. For comparison, of the 493 HIV-only patients, 50 age- and gender-matched consecutive patients for whom baseline and follow-up CD4 counts were available were enrolled as controls. The change from baseline CD4 count was calculated using a paired t-test and Wilcoxon signed rank test. Results. In the present study, among HIV-TB co-infected patients, baseline CD4 levels were 194.52±162.27, and follow-up CD4 levels were 285.09±170.33. A statistically significant increment of 90.57±165.60 in mean CD4 levels was observed (t=4.019; Pt=4.626; PConclusion. Though significant rise in CD4 counts was observed in both HIV-TB co-infected patients and HIV-only patients after 6 to 8 months of appropriate therapy, the rise was significantly higher among the HIV-only group as compared to the HIV-TB co-infected group.Keywords
All Related Versions
This publication has 20 references indexed in Scilit:
- Tuberculosis Co-infection and Associated Factors among People Living with HIV /AIDS Who are on Antiretroviral Therapy in Pastoral Community, Northeast Ethiopia. A Bayesian Analysis ApproachCogent Public Health, 2022
- Prevalence and associated risk factors for tuberculosis among people living with HIV in NepalPLOS ONE, 2022
- Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy studyThe Lancet Infectious Diseases, 2019
- The twin epidemics: Prevalence of TB/HIV co-infection and its associated factors in Ethiopia; A systematic review and meta-analysisPLOS ONE, 2018
- Association of HIV infection with extrapulmonary tuberculosis: a systematic reviewInfection, 2016
- The role of social determinants on tuberculosis/HIV co-infection mortality in southwest Ethiopia: a retrospective cohort studyBMC Research Notes, 2016
- TB/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: a 4 years retrospective studyBMC Research Notes, 2015
- Effects of Tuberculosis on the Kinetics of CD4 + T Cell Count Among HIV-Infected Patients Who Initiated Antiretroviral Therapy Early After Tuberculosis TreatmentAIDS Research and Human Retroviruses, 2013
- New approaches in the diagnosis and treatment of latent tuberculosis infectionRespiratory Research, 2010
- The Growing Burden of TuberculosisArchives of internal medicine (1960), 2003